P&G jumps after Q3 beat, 7% sales growth, and guidance maintained
Procter & Gamble shares are higher after fiscal Q3 2026 results beat expectations, with adjusted EPS of $1.59 on revenue of $21.24 billion. The company reported net sales up 7% and organic sales up 3%, while maintaining full-year EPS guidance of $6.83 to $7.09.
1) What’s moving the stock
Procter & Gamble (PG) is rallying after reporting fiscal third-quarter 2026 results that topped expectations. The company posted adjusted (core) EPS of $1.59 versus an average estimate around $1.56 and revenue of $21.24 billion versus about $20.51 billion expected, supporting a renewed bid for the defensive consumer-staples name. (ctpost.com)
2) Key numbers investors are reacting to
P&G said fiscal Q3 net sales rose 7% year over year to $21.2 billion and organic sales increased 3%. Management attributed organic growth to roughly 2% volume and 1% pricing, pointing to improving demand trends after a period of consumer softness. (files.quartr.com)
3) Guidance and what it signals for the rest of FY2026
P&G maintained its fiscal 2026 guidance ranges, including core EPS growth of in-line to up 4% versus fiscal 2025 core EPS of $6.83, translating to a full-year EPS outlook of $6.83 to $7.09. While guidance was reiterated, the company also indicated it expects results to land toward the lower end of the range due to higher estimated tariff costs and increased reinvestment in innovation and demand creation. (files.quartr.com)
4) One-time and margin details to watch
Reported diluted EPS was $1.63, which included a gain tied to the dissolution of the Glad joint venture business—an item investors will likely normalize when assessing underlying profitability. The release also flagged gross margin pressure versus last year, citing unfavorable mix, reinvestments, and tariff-related costs, partially offset by productivity savings and pricing. (files.quartr.com)